Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pancreatic Neoplasms × aflibercept × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Sarcoma 1 Pancreatic Neoplasms 1 Neurofibromatosis 2 1 Myeloproliferative Disorders 1 Macular Degeneration 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Colorectal Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 86 130-nm albumin-bound paclitaxel 30 Oxaliplatin 27 Fluorouracil 24 Capecitabine 24 Leucovorin 19 Albumin-Bound Paclitaxel 19 Irinotecan 17 Erlotinib Hydrochloride 12 Cyclophosphamide 11 Bevacizumab 10 pembrolizumab 9 Radiotherapy 9 Radiosurgery 9 Nivolumab 9 Surgical Procedures, Operative 8 avelumab 6 Docetaxel 6 Cisplatin 6 ruxolitinib 5 folfirinox 5 Taxes 5 Paclitaxel 5 Everolimus 5 Cetuximab 5 ALT-803 5 spartalizumab 4 Specimen Handling 4 Radiotherapy, Intensity-Modulated 4 Magnetic Resonance Spectroscopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00574275 2016-06-07

VANILLA

Sanofi

Phase 3 Terminated

546 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡